855565443	855565443	CD	B-NP	O
|	|	NN	I-NP	O
RECH	RECH	NN	I-NP	O
|	|	NN	I-NP	O
08530249	08530249	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4127930	4127930	CD	B-NP	O
|	|	CC	I-NP	O
6/21/2006	6/21/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
herpetic	herpetic	JJ	I-NP	O
whitlow	whitlow	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/12/2006	4/12/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
******	******	SYM	B-NP	B-cell_type
FINAL	FINAL	NN	I-NP	I-cell_type
DISCHARGE	DISCHARGE	NN	I-NP	I-cell_type
ORDERS	ORDERS	NNS	I-NP	I-cell_type
******	******	SYM	O	I-cell_type
NIDIFFER	NIDIFFER	NNP	B-NP	O
,	,	,	O	O
MARY	MARY	NNP	B-NP	O
386-79-45-6	386-79-45-6	CD	I-NP	O
Ra	Ra	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/16/06	9/16/06	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VARNEDOE	VARNEDOE	NNP	B-NP	O
,	,	,	O	O
LOREN	LOREN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q8H	Q8H	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TYLENOL	TYLENOL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
388591726	388591726	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	B-NP	O
W/CODEINE	W/CODEINE	NN	I-NP	O
30MG	30MG	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
takes	take	VBZ	B-VP	O
tylenol	tylenol	NN	B-NP	O
alone	alone	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
w/o	w/o	NN	I-NP	O
problems	problem	NNS	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FOSAMAX	FOSAMAX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ALENDRONATE	ALENDRONATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
70	70	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
8	8	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
plain	plain	JJ	B-NP	B-protein
water	water	NN	I-NP	I-protein
LIPITOR	LIPITOR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ATORVASTATIN	ATORVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
+	+	SYM	B-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
500	500	CD	B-NP	O
ELEM	ELEM	NN	I-NP	O
.	.	.	O	O

CA	CA	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
CARBONATE	CARBONATE	NNP	I-NP	O
...	...	:	O	B-DNA
-RRB-	-RRB-	SYM	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
TID	TID	NN	I-NP	I-DNA
CLINDAMYCIN	CLINDAMYCIN	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
450	450	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QID	QID	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
For	For	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

CLOBETASOL	CLOBETASOL	NN	B-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
ERGOCALCIFEROL	ERGOCALCIFEROL	NN	I-NP	O
400	400	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PLAQUENIL	PLAQUENIL	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HYDROXYCHLOROQUINE	HYDROXYCHLOROQUINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
400	400	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
COMBIVENT	COMBIVENT	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
MIDRIN	MIDRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOMETHEPTENE/DICHLORALPHENAZONE/APAP	ISOMETHEPTENE/DICHLORALPHENAZONE/APAP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
CAPSULE	CAPSULE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q2H	Q2H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MIDRIN	MIDRIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
162849000	162849000	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	B-NP	O
W/CODEINE	W/CODEINE	NN	I-NP	O
30MG	30MG	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-protein
w/o	w/o	NN	I-NP	I-protein
problems	problem	NNS	I-NP	I-protein
LEVETIRACETAM	LEVETIRACETAM	NN	I-NP	I-protein
750	750	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
SYNTHROID	SYNTHROID	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
125	125	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
TOPROL	TOPROL	NNP	I-NP	I-protein
XL	XL	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
METOPROLOL	METOPROLOL	NNP	I-NP	I-protein
SUCCINATE	SUCCINATE	NNP	I-NP	I-protein
EXTENDED	EXTENDED	NNP	I-NP	I-protein
RELEASE	RELEASE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PRILOSEC	PRILOSEC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
OXCARBAZEPINE	OXCARBAZEPINE	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PHENOBARBITAL	PHENOBARBITAL	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PREDNISONE	PREDNISONE	NNP	B-NP	O
&	&	CC	I-NP	O
PHENOBARBITAL	PHENOBARBITAL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PREDNISONE	PREDNISONE	NNP	B-NP	O
&	&	CC	I-NP	O
PHENOBARBITAL	PHENOBARBITAL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
PRAMOXINE	PRAMOXINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
1	1	CD	B-NP	O
%	%	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
TID	TID	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Itching	Itching	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Apply	Apply	RB	B-ADVP	O
to	to	TO	B-PP	O
itching	itch	VBG	B-VP	O
skin	skin	NN	B-NP	O
PREDNISONE	PREDNISONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Manual	Manual	NNP	B-NP	O
Seryak	Seryak	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ERKER	ERKER	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/5/06	1/5/06	CD	I-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
:	:	SYM	I-NP	O
10	10	CD	I-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ZASSO	ZASSO	NNP	B-NP	B-protein
,	,	,	O	O
JASON	JASON	NNP	B-NP	O
DEMARCUS	DEMARCUS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RHEUM	RHEUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/9/06	3/9/06	CD	I-NP	O
,	,	,	I-NP	O
10	10	CD	I-NP	O
am	am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
OSLER	OSLER	NNP	B-NP	O
,	,	,	O	O
PEDRO	PEDRO	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PH	M.PH	NNP	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
DERM	DERM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/1/06	10/1/06	CD	I-NP	O
,	,	,	I-NP	O
9	9	CD	I-NP	O
:	:	SYM	I-NP	O
45	45	CD	I-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
PHENYTOIN	PHENYTOIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
ACETAMINOPHEN	ACETAMINOPHEN	NNP	B-NP	O
W/CODEINE	W/CODEINE	NNP	I-NP	O
30MG	30MG	NNP	I-NP	O
,	,	,	O	O
Morphine	Morphine	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
herpetic	herpetic	JJ	B-NP	O
whitlow	whitlow	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
herpetic	herpetic	JJ	I-NP	O
whitlow	whitlow	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
SLE	SLE	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
seizure	seizure	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
seizure	seizure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osteoporosis	osteoporosis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
osteoporosis	osteoporosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osteogenesis	osteogenesis	NN	I-NP	O
imperfecta	imperfecta	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
osteogenesis	osteogenesis	NN	I-NP	O
imperfecta	imperfecta	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
disseminated	disseminate	VBD	B-VP	O
VZV	VZV	NN	B-NP	B-protein
PE	PE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
pulmonary	pulmonary	JJ	I-NP	I-protein
embolism	embolism	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
CVA	CVA	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Clindamycin	Clindamycin	NNP	I-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
X	X	SYM	I-NP	O
3	3	CD	I-NP	O
doses	dose	NNS	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
herpetic	herpetic	JJ	B-NP	O
whitlow	whitlow	JJ	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
56F	56F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
SLE	SLE	NN	I-NP	O
c/b	c/b	NN	I-NP	O
lupus	lupus	NN	I-NP	O
nephritis	nephritis	NN	I-NP	O
and	and	CC	O	O
PE	PE	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
for	for	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
past	past	JJ	B-NP	B-protein
30	30	CD	I-NP	I-protein
yrs	yr	NNS	I-NP	I-protein
,	,	,	O	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
disseminated	disseminate	VBN	B-VP	O
VZV	VZV	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CVA	CVA	NN	I-NP	O
X3	X3	NN	I-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
d/o	d/o	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
comes	come	VBZ	B-VP	O
to	to	TO	B-PP	O
ED	ED	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
increasing	increase	VBG	B-VP	O
R	R	NN	B-NP	B-protein
middle	middle	JJ	I-NP	I-protein
finger	finger	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
noted	note	VBD	B-VP	O
vesicles	vesicle	NNS	B-NP	O
on	on	IN	B-PP	O
medial	medial	JJ	B-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
affected	affect	VBN	B-NP	O
finger	finger	NN	I-NP	O
over	over	IN	B-PP	O
past	past	JJ	B-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
accidentally	accidentally	RB	B-ADVP	O
nicked	nick	VBD	B-VP	O
skin	skin	NN	B-NP	O
just	just	RB	B-ADVP	O
below	below	IN	B-PP	O
these	these	DT	B-NP	O
vesicles	vesicle	NNS	I-NP	O
,	,	,	O	O
developed	develop	VBD	B-VP	O
small	small	JJ	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
erythema	erythema	NN	B-NP	O
that	that	WDT	B-NP	O
spread	spread	VBD	B-VP	O
to	to	TO	B-PP	O
backside	backside	NN	B-NP	O
of	of	IN	B-PP	O
finger	finger	NN	B-NP	O
and	and	CC	O	O
back	back	RB	B-ADVP	O
of	of	IN	B-PP	O
palm	palm	NN	B-NP	B-protein
over	over	IN	B-PP	I-protein
48	48	CD	B-NP	I-protein
hrs	hr	NNS	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
noted	note	VBD	B-VP	O
some	some	DT	B-NP	O
weeping	weeping	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
vesicles	vesicle	NNS	I-NP	O
evening	evening	NN	I-NP	O
PTA	PTA	NN	I-NP	O
,	,	,	O	O
so	so	RB	O	O
sent	sent	JJ	B-NP	O
Pt	Pt	NN	I-NP	O
to	to	TO	B-PP	O
ED	ED	NN	B-NP	O
for	for	IN	B-PP	O
eval	eval	NN	B-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
arrival	arrival	JJ	B-NP	O
Pt	Pt	NN	I-NP	O
c/o	c/o	NN	I-NP	O
10/10	10/10	CD	I-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
skin	skin	NN	B-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

Denied	Deny	VBN	B-NP	O
f/c	f/c	NN	I-NP	O
,	,	,	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
R	R	NN	B-NP	B-protein
middle	middle	JJ	I-NP	I-protein
finger	finger	NN	I-NP	I-protein
,	,	,	O	O
joint	joint	JJ	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
affected	affect	VBN	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
IV	IV	CD	I-NP	O
X2	X2	NN	I-NP	O
,	,	,	O	O
seen	see	VBN	B-VP	O
by	by	IN	B-PP	O
Ortho	Ortho	NNP	B-NP	O
hand	hand	NN	I-NP	O
who	who	WP	B-NP	O
dx	dx	VBP	B-VP	O
'd	'd	POS	B-NP	O
cellulitic	cellulitic	JJ	I-NP	O
superinfxn	superinfxn	NN	I-NP	O
of	of	IN	B-PP	O
herpetic	herpetic	JJ	B-NP	O
whitlow	whitlow	NN	I-NP	O
,	,	,	O	O
felt	feel	VBD	B-VP	O
joints	joint	NNS	B-NP	O
not	not	RB	B-VP	O
involved	involve	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
marked	marked	JJ	B-NP	O
boundaries	boundary	NNS	I-NP	O
.	.	.	O	O

Rec	Rec	NN	B-NP	O
=	=	SYM	B-NP	O
give	give	VB	B-VP	O
IV	IV	CD	B-NP	O
clinda	clinda	NN	I-NP	O
,	,	,	O	O
observe	observe	NN	B-NP	O
,	,	,	O	O
could	could	MD	B-VP	O
send	send	VB	I-VP	O
home	home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
PO	PO	NN	I-NP	O
clinda	clinda	NN	I-NP	O
if	if	IN	B-SBAR	O
improved	improve	VBN	B-VP	O
over	over	IN	B-PP	O
8-12	8-12	CD	B-NP	O
hrs	hr	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
hx	hx	NN	I-NP	O
SLE	SLE	NN	I-NP	O
+	+	SYM	B-VP	O
prednisone	prednisone	NN	B-NP	O
use	use	NN	I-NP	O
and	and	CC	O	O
?	?	.	O	O

of	of	IN	B-PP	O
DM2	DM2	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
turns	turn	VBZ	B-VP	O
out	out	RP	B-PRT	O
not	not	RB	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
clear	clear	JJ	B-NP	O
DM	DM	NN	I-NP	O
after	after	IN	B-PP	O
chart	chart	NN	B-NP	O
Bx	Bx	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Pt	Pt	NN	B-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
observation	observation	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
denied	deny	VBN	B-VP	O
f/c	f/c	NN	B-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
N/V/D	N/V/D	NN	B-NP	B-protein
,	,	,	O	O
any	any	DT	B-NP	O
residual	residual	JJ	I-NP	O
pain	pain	NN	I-NP	O
over	over	IN	B-PP	O
R	R	NN	B-NP	B-protein
middle	middle	JJ	I-NP	I-protein
finger	finger	NN	I-NP	I-protein
.	.	.	O	O

Noted	Note	VBD	B-VP	O
that	that	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
redness	redness	NN	B-NP	O
over	over	IN	B-PP	O
finger	finger	NN	B-NP	O
had	have	VBD	B-VP	O
rapidly	rapidly	RB	I-VP	O
receeded	receede	VBN	I-VP	O
and	and	CC	O	O
joints	joint	NNS	B-NP	O
remained	remain	VBD	B-VP	O
nontender	nontender	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
frustrated	frustrate	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
long	long	JJ	I-NP	O
ED	ED	NN	I-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
disagreed	disagree	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
DM	DM	NN	I-NP	O
dx	dx	NN	I-NP	O
.	.	.	O	O

Strongly	Strongly	RB	B-ADVP	O
opposed	oppose	VBN	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
given	give	VBN	I-NP	O
improvement	improvement	NN	B-NP	O
,	,	,	O	O
asked	ask	VBD	B-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
from	from	IN	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
SLE	SLE	NN	B-NP	O
,	,	,	O	O
discoid	discoid	JJ	B-NP	O
lupus	lupus	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
disseminated	disseminate	VBN	B-VP	O
VZV	VZV	NN	B-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
d/o	d/o	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
since	since	IN	B-PP	O
childhood	childhood	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
migraines	migraine	NNS	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-VP	O
HTN/hyperlipidemia	HTN/hyperlipidemia	NN	B-NP	O
,	,	,	O	O
NSTEMI	NSTEMI	NN	B-NP	B-protein
10/25	10/25	CD	I-NP	I-protein
,	,	,	O	O
CVA	CVA	NN	B-NP	B-protein
X3	X3	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
last	last	JJ	B-NP	I-protein
2004	2004	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
osteoperosis	osteoperosis	NN	B-NP	O
,	,	,	O	O
osetogenical	osetogenical	JJ	B-NP	O
imperfecta	imperfecta	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
PE	PE	NNP	I-NP	O
Home	Home	NNP	I-NP	O
Meds	Med	NNPS	I-NP	O
:	:	:	O	O
Pre-admission	Pre-admission	NNP	B-NP	O
Medication	Medication	NNP	I-NP	O
List	List	NNP	I-NP	O
for	for	IN	B-PP	O
SKILLPA	SKILLPA	NNP	B-NP	O
,	,	,	O	O
JARVIS	JARVIS	NNP	B-NP	O
08530249	08530249	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
DLHO	DLHO	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
56	56	CD	I-NP	O
F	F	NN	I-NP	O
Last	Last	NN	I-NP	O
saved	save	VBN	B-VP	O
by	by	IN	B-PP	O
:	:	:	O	O
MAZARIEGO	MAZARIEGO	NNP	B-NP	O
,	,	,	O	O
NATHANIEL	NATHANIEL	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
4/12/2006	4/12/2006	CD	B-NP	O
at	at	IN	B-PP	O
13	13	CD	B-NP	O
:	:	:	O	O
09	09	CD	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Acetaminophen	Acetaminophen	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
Tylenol	Tylenol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PO	PO	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
Q8h	Q8h	NN	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
back	back	JJ	I-NP	B-protein
pain	pain	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Acetylsalicylic	Acetylsalicylic	JJ	B-NP	O
Acid	Acid	NN	I-NP	O
PO	PO	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Alendronate	Alendronate	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
Fosamax	Fosamax	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PO	PO	NN	I-NP	O
70	70	CD	I-NP	O
MG	MG	NN	I-NP	O
QWEEK	QWEEK	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
8	8	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
plain	plain	JJ	B-NP	B-protein
water	water	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Atorvastatin	Atorvastatin	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Lipitor	Lipitor	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
QHS	QHS	NNP	I-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
Carbonate	Carbonate	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
Mg	Mg	NN	I-NP	O
Elemental	Elemental	JJ	I-NP	O
Ca	Ca	NN	I-NP	O
+	+	SYM	O	O
+	+	SYM	O	O
-RRB-	-RRB-	SYM	O	O
PO	PO	NN	B-NP	O
1250	1250	CD	I-NP	O
MG	MG	NN	I-NP	O
TID	TID	NN	I-NP	O
in	in	IN	B-PP	O
between	between	IN	B-PP	O
MEALS	MEALS	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Clobetasol	Clobetasol	NN	B-NP	O
Propionate	Propionate	NN	I-NP	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
TOP	TOP	NN	I-NP	O
1	1	CD	I-NP	O
APPLICATION	APPLICATION	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Ergocalciferol	Ergocalciferol	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Vitamin	Vitamin	NNP	I-NP	O
D	D	NNP	I-NP	O
25-Oh	25-Oh	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
400	400	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QD	QD	NN	I-NP	B-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Hydroxychloroquine	Hydroxychloroquine	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Plaquenil	Plaquenil	NNP	I-NP	O
Sulfate	Sulfate	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Ipratropium	Ipratropium	NNP	B-NP	O
And	And	NNP	I-NP	O
Albuterol	Albuterol	NNP	I-NP	O
Sulfate	Sulfate	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Combivent	Combivent	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
INH	INH	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
QID	QID	NN	I-NP	O
prn	prn	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	B-DNA
10	10	CD	I-NP	I-DNA
.	.	.	O	O

Isometheptene/Dichloralphenazone/Apap	Isometheptene/Dichloralphenazone/Apap	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
Midrin	Midrin	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PO	PO	NN	I-NP	O
1	1	CD	I-NP	O
CAPSULE	CAPSULE	NN	I-NP	O
Q1H	Q1H	NN	I-NP	O
prn	prn	NN	I-NP	O
Headache	Headache	NNP	I-NP	O
Up	Up	NNP	I-NP	O
to	to	TO	B-PP	O
6	6	CD	B-NP	O
capsules	capsule	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Levetiracetam	Levetiracetam	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Keppra	Keppra	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
750	750	CD	I-NP	O
MG	MG	NN	I-NP	O
BID	BID	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Levothyroxine	Levothyroxine	NNP	B-NP	O
Sodium	Sodium	NNP	I-NP	O
PO	PO	NNP	I-NP	O
125	125	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
QD	QD	NNP	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
PO	PO	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Metoprolol	Metoprolol	NNP	B-NP	O
Succinate	Succinate	NNP	I-NP	O
Extended	Extended	NNP	I-NP	O
Release	Release	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Toprol	Toprol	NNP	I-NP	O
Xl	Xl	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Omeprazole	Omeprazole	NN	B-NP	O
Otc	Otc	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Prilosec	Prilosec	NNP	I-NP	O
Otc	Otc	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
QD	QD	NNP	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Oxcarbazepine	Oxcarbazepine	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Trileptal	Trileptal	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
BID	BID	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Phenobarbital	Phenobarbital	NN	B-NP	O
PO	PO	NN	I-NP	O
64.8	64.8	CD	I-NP	O
MG	MG	NN	I-NP	O
BID	BID	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
PO	PO	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

Simethicone	Simethicone	NN	B-NP	O
PO	PO	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
QID	QID	NN	I-NP	O
prn	prn	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
gas	gas	NN	B-NP	B-DNA
,	,	,	O	O
indigestion	indigestion	NN	B-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Warfarin	Warfarin	NNP	B-NP	O
Sodium	Sodium	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
21	21	CD	B-NP	O
.	.	.	O	O

Simethicone	Simethicone	NN	B-NP	O
prn	prn	NN	I-NP	O
Allergies	Allergy	NNS	I-NP	O
:	:	:	O	O
Phenytoin	Phenytoin	NN	B-NP	O
,	,	,	O	O
PCNs	PCN	NNS	B-NP	B-protein
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
,	,	,	O	O
Morphine	Morphine	NNP	B-NP	O
--	--	:	O	O
SHx	SHx	NNP	B-NP	O
:	:	:	O	O
Lives	Live	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
daugther	daugther	NN	B-NP	O
,	,	,	O	O
Spanish-speaking	Spanish-speaking	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
daughters	daughter	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
sons	son	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tob	tob	NN	I-NP	B-protein
,	,	,	O	O
EtOH	EtOH	NN	B-NP	B-protein
,	,	,	O	O
drugs	drug	NNS	B-NP	O
.	.	.	O	O

FHx	FHx	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
son	son	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
epilepsy	epilepsy	NN	B-NP	O
,	,	,	O	O
sister	sister	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
SLE	SLE	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
autoimmune	autoimmune	JJ	I-NP	O
dz	dz	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
CA	CA	NN	I-NP	O
,	,	,	I-NP	O
son	son	NN	I-NP	O
and	and	CC	I-NP	O
daughter	daughter	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
``	``	``	O	O
heart	heart	NN	B-NP	O
dz	dz	NN	I-NP	O
''	''	''	I-NP	O
ROS	ROS	NN	I-NP	O
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
headache	headache	NN	I-NP	O
,	,	,	O	O
hungry	hungry	NN	B-NP	O
.	.	.	O	O

Rest	Rest	RBS	B-ADJP	O
negative	negative	JJ	I-ADJP	O
except	except	IN	B-PP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
HPI	HPI	NN	B-NP	B-protein
.	.	.	O	O

--	--	:	O	O
EXAM	EXAM	NN	B-NP	O
:	:	:	O	O
97	97	CD	B-NP	O
63118/78	63118/78	CD	I-NP	O
12	12	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Comfortable	Comfortable	NNP	I-NP	O
,	,	,	O	O
arm	arm	NN	B-NP	O
elevated	elevate	VBD	B-VP	O
in	in	IN	B-PP	O
sling	sling	VBG	B-NP	O
,	,	,	O	O
eating	eat	VBG	B-VP	O
lunch	lunch	NN	B-NP	O
,	,	,	O	O
A	A	NNP	B-NP	O
&	&	CC	I-NP	O
OX	OX	NNP	I-NP	O
3	3	CD	I-NP	O
OP	OP	NN	I-NP	O
clear	clear	JJ	I-NP	O
,	,	,	I-NP	O
slightly	slightly	RB	I-NP	O
blue	blue	JJ	I-NP	O
sclera	sclera	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
CTAB	CTAB	NN	I-NP	I-protein
RRR	RRR	NN	I-NP	I-protein
,	,	,	O	O
s1	s1	NN	B-NP	O
=	=	SYM	B-VP	O
s2	s2	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
Obese	Obese	NN	I-NP	O
,	,	,	O	O
NT	NT	NN	B-NP	O
,	,	,	O	O
ND	ND	NN	B-NP	O
,	,	,	O	O
+	+	SYM	O	O
BS	BS	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
appreciable	appreciable	JJ	I-NP	O
organomegaly	organomegaly	NN	I-NP	O
No	No	DT	B-NP	O
c/c/e	c/c/e	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
;	;	:	O	O
thining	thin	VBG	B-VP	O
hair	hair	NN	B-NP	O
over	over	IN	B-PP	O
scalp	scalp	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
central	central	JJ	I-NP	O
alopecia	alopecia	NN	I-NP	O
R	R	NN	I-NP	O
hand	hand	NN	I-NP	O
:	:	:	O	O
confluent	confluent	JJ	B-NP	O
vesciles	vescile	NNS	I-NP	O
over	over	IN	B-PP	O
medial	medial	JJ	B-NP	O
3rd	3rd	NN	I-NP	O
digit	digit	NN	I-NP	O
DIP	DIP	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
TTP	TTP	NN	I-NP	B-protein
over	over	IN	B-PP	O
DIP/PIP/MCP	DIP/PIP/MCP	NN	B-NP	O
,	,	,	O	O
redness	redness	NN	B-NP	O
surrounding	surrounding	NN	I-NP	O
vesicles	vesicle	NNS	I-NP	O
w/o	w/o	VBP	B-VP	O
exudate	exudate	NN	B-NP	O
and	and	CC	O	O
receeding	receede	VBG	B-VP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
points	point	NNS	I-NP	O
from	from	IN	B-PP	O
marked	marked	JJ	B-NP	O
boundaries	boundary	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
soft	soft	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
swelling	swell	VBG	B-VP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
conpartment	conpartment	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
Neuro	Neuro	NN	I-NP	O
nonfocal	nonfocal	JJ	B-ADJP	O
--	--	:	O	O
Relevant	Relevant	JJ	B-NP	O
studies/Labs	studies/Lab	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
sent	send	VBN	B-VP	O
from	from	IN	B-PP	O
ED	ED	VBN	B-VP	O
--	--	:	O	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
Impression	Impression	NN	B-NP	O
:	:	:	O	O
62F	62F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
SLE	SLE	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	O
disseminated	disseminate	VBD	B-VP	O
VZV	VZV	NN	B-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
d/o	d/o	NN	I-NP	O
here	here	RB	B-NP	O
w	w	JJ	I-NP	O
/	/	SYM	I-NP	O
herpetic	herpetic	JJ	I-NP	O
whitlow	whitlow	JJ	I-NP	O
and	and	CC	I-NP	O
bacterial	bacterial	JJ	I-NP	O
superinfection/cellulitis	superinfection/cellulitis	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

ID/Cellultis	ID/Cellultis	NN	B-NP	O
overlying	overlie	VBG	B-VP	O
herpetic	herpetic	JJ	B-NP	O
whitlow	whitlow	NN	I-NP	O
--	--	:	O	O
Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
infection	infection	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
markedly	markedly	RB	I-VP	O
improved	improve	VBN	I-VP	O
from	from	IN	B-PP	O
ED	ED	JJ	B-NP	O
presentation	presentation	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
by	by	IN	B-PP	O
admitting	admit	VBG	B-VP	O
Medicine	Medicine	NN	B-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-NP	O
h/o	h/o	NN	I-NP	O
SLE	SLE	NN	I-NP	O
and	and	CC	I-NP	O
prednisone	prednisone	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
making	make	VBG	B-VP	O
Pt	Pt	NN	B-NP	O
functionally	functionally	RB	B-VP	O
immunosupressed	immunosupresse	VBN	I-VP	O
,	,	,	O	O
indication	indication	NN	B-NP	O
for	for	IN	B-PP	O
conservative	conservative	JJ	B-NP	O
management	management	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
admission	admission	NN	B-NP	O
and	and	CC	I-NP	O
observation	observation	NN	I-NP	O
reasonable	reasonable	NN	I-NP	O
.	.	.	O	O

Per	Per	NN	B-NP	O
record	record	NN	I-NP	O
,	,	,	O	O
Pt	Pt	NN	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
official	official	JJ	B-NP	O
Dx	Dx	NN	I-NP	O
of	of	IN	B-PP	O
DM2	DM2	NN	B-NP	B-protein
--	--	:	O	O
?	?	.	O	O

elevated	elevated	JJ	B-NP	O
Gluc	Gluc	NN	I-NP	O
in	in	IN	B-PP	O
past	past	JJ	B-NP	O
2/2	2/2	CD	I-NP	O
steroid	steroid	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
very	very	RB	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
staying	stay	VBG	B-VP	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
her	her	PRP$	B-NP	O
finger	finger	NN	I-NP	O
was	be	VBD	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
completely	completely	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
,	,	,	O	O
margins	margin	NNS	B-NP	O
all	all	DT	O	O
receeded	receede	VBD	B-VP	O
from	from	IN	B-PP	O
marked	marked	JJ	B-NP	O
borders	border	NNS	I-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
f/c	f/c	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
joint	joint	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Reviewed	Reviewed	NNP	B-NP	O
Ortho	Ortho	NNP	I-NP	O
hand	hand	NN	I-NP	O
recs	rec	NNS	I-NP	O
,	,	,	O	O
plan	plan	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
Medicine	Medicine	NN	I-NP	O
attending	attend	VBG	I-NP	O
and	and	CC	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
Pt	Pt	NN	B-NP	O
displayed	display	VBD	B-VP	O
excellent	excellent	JJ	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
Dx	Dx	NN	B-NP	O
,	,	,	O	O
indications	indication	NNS	B-NP	O
for	for	IN	B-PP	O
return	return	NN	B-NP	O
to	to	TO	B-PP	O
hospital	hospital	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
desire	desire	NN	B-NP	O
for	for	IN	B-PP	O
adherence	adherence	NN	B-NP	O
,	,	,	O	O
agreed	agree	VBD	B-VP	O
to	to	TO	I-VP	O
d/c	d/c	VB	I-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	VBN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
oral	oral	JJ	I-NP	O
Clindamycin	Clindamycin	NN	I-NP	O
450	450	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qid	qid	NN	I-NP	O
and	and	CC	O	O
close	close	JJ	B-NP	O
f/u	f/u	NN	I-NP	O
in	in	IN	B-PP	O
LOMU	LOMU	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
PCP	PCP	NN	I-NP	O
on	on	IN	B-PP	O
10/17	10/17	CD	B-NP	O
Given	Give	VBN	B-VP	O
a	a	DT	B-NP	O
final	final	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Clinda	Clinda	NNP	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
before	before	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

Decision	Decision	NNP	B-NP	O
made	make	VBD	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
provide	provide	VB	I-VP	O
Rx	Rx	NN	B-NP	B-protein
for	for	IN	B-PP	O
herpetic	herpetic	JJ	B-NP	O
whitlow	whitlow	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
time	time	NN	I-NP	O
given	give	VBN	B-VP	O
Pt	Pt	NNP	B-NP	O
's	's	POS	B-NP	O
many	many	JJ	I-NP	O
allergies	allergy	NNS	I-NP	O
and	and	CC	I-NP	O
brief	brief	JJ	I-NP	O
literature	literature	NN	I-NP	O
review	review	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
notes	note	VBZ	B-VP	O
controversy	controversy	NN	B-NP	O
over	over	IN	B-PP	O
acyclovir	acyclovir	NN	B-NP	O
Rx	Rx	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
most	most	JJS	B-NP	O
cases	case	NNS	I-NP	O
resolve	resolve	VBP	B-VP	O
spontaneously	spontaneously	RB	B-ADVP	O
in	in	IN	B-PP	O
2-3	2-3	CD	B-NP	O
wks	wk	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
readdress	readdress	VB	I-VP	O
at	at	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
visit	visit	NN	I-NP	I-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

SLE	SLE	NN	B-NP	O
--	--	:	O	O
no	no	DT	B-NP	O
e/o	e/o	NN	I-NP	O
flare	flare	NN	I-NP	O
,	,	,	O	O
cont	cont	JJ	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
--	--	:	O	O
none	none	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	JJ	B-NP	O
,	,	,	I-NP	O
cont	cont	JJ	I-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
4	4	CD	B-NP	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
--	--	:	O	O
cont	cont	VBP	B-VP	O
home	home	NN	B-NP	B-protein
meds	med	NNS	I-NP	I-protein
5	5	CD	B-NP	I-protein
.	.	.	O	O

Seizure	Seizure	NN	B-NP	O
d/o	d/o	NN	I-NP	O
--	--	:	O	O
last	last	JJ	B-NP	O
seizure	seizure	NN	I-NP	O
8/24/06	8/24/06	CD	I-NP	O
per	per	IN	B-PP	O
Neuro	Neuro	NNP	B-NP	O
outPt	outPt	NN	I-NP	O
record	record	NN	I-NP	O
,	,	,	O	O
none	none	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

Cont	Cont	JJ	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
6	6	CD	B-NP	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
h/o	h/o	NN	I-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
--	--	:	O	O
cont	cont	VBP	B-VP	O
ASA	ASA	NN	B-NP	O
,	,	,	I-NP	O
HTN	HTN	NN	I-NP	B-protein
and	and	CC	I-NP	O
lipid	lipid	NN	I-NP	B-protein
control	control	NN	I-NP	I-protein
regimen	regimen	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

h/o	h/o	NN	B-NP	O
PE	PE	NN	I-NP	O
--	--	:	O	O
no	no	DT	B-NP	O
e/o	e/o	NN	I-NP	O
recurrent	recurrent	NN	I-NP	O
,	,	,	O	O
cont	cont	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

h/o	h/o	RB	B-ADVP	O
CVA	CVA	NNP	B-NP	O
--	--	:	O	O
Neuro	Neuro	NNP	B-NP	O
exam	exam	NN	I-NP	O
nonfocal	nonfocal	JJ	I-NP	O
,	,	,	I-NP	O
cont	cont	JJ	I-NP	O
coumadin	coumadin	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
--	--	:	O	O
cont	cont	VBP	B-VP	O
synthroid	synthroid	JJ	B-NP	O
FEN	FEN	NNP	I-NP	O
--	--	:	O	O
Cards	Card	NNS	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
POs	PO	NNS	B-NP	B-protein
,	,	,	O	O
chem7	chem7	NN	B-NP	O
qd	qd	NN	I-NP	O
Ppx	Ppx	NN	I-NP	O
--	--	:	O	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
tylenol	tylenol	NN	B-NP	O
,	,	,	O	O
dilaudid	dilaudid	NN	B-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
regimen	regimen	NN	I-NP	O
Code	Code	NN	I-NP	O
--	--	:	O	O
Full	Full	JJ	B-NP	O
ADDITIONAL	ADDITIONAL	JJ	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Return	Return	NN	B-NP	O
to	to	TO	B-PP	O
ED	ED	NNP	B-NP	O
for	for	IN	B-PP	O
increasing	increase	VBG	B-VP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
right	right	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
swelling	swelling	NN	B-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
your	your	PRP$	B-NP	O
right	right	JJ	I-NP	O
hand	hand	NN	I-NP	O
or	or	CC	O	O
middle	middle	JJ	B-NP	O
finger	finger	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
worrisome	worrisome	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

take	take	VB	B-VP	O
full	full	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	B-protein
2	2	CD	B-NP	I-protein
.	.	.	O	O

follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
on	on	IN	B-PP	O
1/5/06	1/5/06	CD	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CHARY	CHARY	NNP	B-NP	O
,	,	,	O	O
NELSON	NELSON	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QY37	QY37	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/16/06	9/16/06	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

